project id: TCGA-MESO; case submitter id: TCGA-MQ-A4KX; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.09; rna integrity number: 7.6; age at index: 55; days to birth: -20336; days to death: 2459; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1947; year of death: 2008; age at diagnosis: 20336; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C45.0; last known disease status: not reported; morphology: 9052/3; primary diagnosis: Epithelioid mesothelioma, malignant; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Pleura, NOS; synchronous malignancy: No; tissue or organ of origin: Pleura, NOS; tumor grade: Not Reported; year of diagnosis: 2002; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; initial weight: 290.0; sample id: 8dbe59ba-5440-4062-97e3-7817e229e2b7; sample submitter id: TCGA-MQ-A4KX-01A; portion id: 4abf2bda-12a6-45f2-8673-72121d5027c1; portion submitter id: TCGA-MQ-A4KX-01A-11; slide id: d7f0d67e-ad38-4ae0-9153-c5e5470b89b7; slide submitter id: TCGA-MQ-A4KX-01A-01-TSA; percent lymphocyte infiltration: 15.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 70.0; percent tumor cells: 30.0; percent tumor nuclei: 85.0; section location: TOP;